What does Apotheek As do?

Apotheek As is a pharmacy in As. Private Limited, started on 11 February 1988, 1 establishment.

What is the address of Apotheek As?

The registered office of Apotheek As is located at Steenweg 30, 3665 As.

Is Apotheek As still active?

Yes. According to the CBE (30 October 2026) Apotheek As is active, legal situation “Normale toestand”, started on 11 February 1988.

Is Apotheek As registered on Peppol?

Yes, Apotheek As is registered on the Peppol network with ID 0208:0433387981.

What is the enterprise number of Apotheek As?

The enterprise number of Apotheek As is BE0433387981.

When was Apotheek As founded?

Apotheek As was founded on 11 February 1988.

Who are the directors of Apotheek As?

According to the 2025 annual accounts, the directors of Apotheek As are: CURAMIS BV, ARKOPHAR BV.

Is Apotheek As a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 February 1988; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Apotheek As make in 2025?

Apotheek As posted a profit after taxes of € 42,742 in financial year 2025.

What is the revenue of Apotheek As?

As a small company, Apotheek As is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 123,582.

How much does an employee at Apotheek As earn?

The average wage cost per full-time employee at Apotheek As was € 37,900 in 2025: staff costs of € 56,816 for 1.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek As have?

According to the 2025 annual accounts, Apotheek As has 1.5 full-time equivalents (FTE).

Does Apotheek As have a website?

Yes, Apotheek As has a website at apotheekas.be.

Apotheek As (Private Limited) - As - BE0433387981

Dossier Apotheek As, printed on 30 October 2026 from databakkes.be/en/0433387981/apotheek-as. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek As from As, company number BE0433387981, closed financial year 2025 with a result of € 42,742 after tax. For that financial year Apotheek As recorded a gross margin of € 123,582 and equity of € 158,734. Compared with financial year 2024, the result moved from € 106,232 to € 42,742. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 13, 2026.

What it is worth Healthy

€ 158,734

▼ 29% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 42,742

▼ 60% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 233,070

▲ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 106,946 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

1.5

▲ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 56,816

▲ 5% vs 2024

€ 37,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 7,696

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 17 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 308,404

▲ 59% vs 2024

€ 10,955 is repaid this year. At this pace the long-term loan is gone in ≈ 17 years.

Owed to suppliers

€ 192,632

▲ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 11,279

▲ 16% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 346,301 Gross margin 2022: € 346,301 First fiscal year in the series	€ 585,590 Gross margin 2023: € 585,590 ▲ 69% vs 2022 (€ 346,301) Favourable step	€ 183,690 Gross margin 2024: € 183,690 ▼ 69% vs 2023 (€ 585,590) Unfavourable step	€ 123,582 Gross margin 2025: € 123,582 ▼ 33% vs 2024 (€ 183,690) Unfavourable step	▼ 33%
Profit after taxes	€ 143,063 Profit after taxes 2022: € 143,063 First fiscal year in the series	€ 330,800 Profit after taxes 2023: € 330,800 ▲ 131% vs 2022 (€ 143,063) Favourable step	€ 106,232 Profit after taxes 2024: € 106,232 ▼ 68% vs 2023 (€ 330,800) Unfavourable step	€ 42,742 Profit after taxes 2025: € 42,742 ▼ 60% vs 2024 (€ 106,232) Unfavourable step	▼ 60%
Equity	€ 1,263,677 Equity 2022: € 1,263,677 First fiscal year in the series	€ 816,705 Equity 2023: € 816,705 ▼ 35% vs 2022 (€ 1,263,677) Unfavourable step	€ 222,938 Equity 2024: € 222,938 ▼ 73% vs 2023 (€ 816,705) Unfavourable step	€ 158,734 Equity 2025: € 158,734 ▼ 29% vs 2024 (€ 222,938) Unfavourable step	▼ 29%
Total debts	€ 1,261,895 Total debts 2022: € 1,261,895 First fiscal year in the series	€ 1,429,218 Total debts 2023: € 1,429,218 ▲ 13% vs 2022 (€ 1,261,895) Unfavourable step	€ 607,802 Total debts 2024: € 607,802 ▼ 57% vs 2023 (€ 1,429,218) Favourable step	€ 625,265 Total debts 2025: € 625,265 ▲ 3% vs 2024 (€ 607,802) Unfavourable step	▲ 3%
Cash	€ 2,208,618 Cash 2022: € 2,208,618 First fiscal year in the series	€ 684,497 Cash 2023: € 684,497 ▼ 69% vs 2022 (€ 2,208,618) Unfavourable step	€ 190,462 Cash 2024: € 190,462 ▼ 72% vs 2023 (€ 684,497) Unfavourable step	€ 233,070 Cash 2025: € 233,070 ▲ 22% vs 2024 (€ 190,462) Favourable step	▲ 22%
Land & buildings	€ 14,688 Land & buildings 2022: € 14,688 First fiscal year in the series	€ 13,372 Land & buildings 2023: € 13,372 ▼ 9% vs 2022 (€ 14,688) Unchanged	€ 12,899 Land & buildings 2024: € 12,899 ▼ 4% vs 2023 (€ 13,372) Unchanged	€ 12,881 Land & buildings 2025: € 12,881 Unchanged (€ 12,899) Unchanged
Retained profit	€ 1,245,077 Retained profit 2022: € 1,245,077 First fiscal year in the series	€ 798,105 Retained profit 2023: € 798,105 ▼ 36% vs 2022 (€ 1,245,077) Unfavourable step	€ 204,338 Retained profit 2024: € 204,338 ▼ 74% vs 2023 (€ 798,105) Unfavourable step	€ 140,134 Retained profit 2025: € 140,134 ▼ 31% vs 2024 (€ 204,338) Unfavourable step	▼ 31%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 777,772 Dividend 2023: € 777,772 Unchanged (€ 0) Unchanged	€ 700,000 Dividend 2024: € 700,000 ▼ 10% vs 2023 (€ 777,772) Unchanged	€ 106,946 Dividend 2025: € 106,946 ▼ 85% vs 2024 (€ 700,000) Unchanged	▼ 85%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 193,990 Bank debt 2024: € 193,990 Unchanged (€ 0) Unfavourable step	€ 308,404 Bank debt 2025: € 308,404 ▲ 59% vs 2024 (€ 193,990) Unfavourable step	▲ 59%
Balance sheet total	€ 2,525,572 Balance sheet total 2022: € 2,525,572 First fiscal year in the series	€ 2,245,923 Balance sheet total 2023: € 2,245,923 ▼ 11% vs 2022 (€ 2,525,572) Unchanged	€ 830,739 Balance sheet total 2024: € 830,739 ▼ 63% vs 2023 (€ 2,245,923) Unchanged	€ 783,998 Balance sheet total 2025: € 783,998 ▼ 6% vs 2024 (€ 830,739) Unchanged	▼ 6%
Employees (FTE)	1.7 Employees (FTE) 2022: 1.7 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 Unchanged (1.7) Unchanged	1.1 Employees (FTE) 2024: 1.1 ▼ 0.6 vs 2023 (1.7) Unchanged	1.5 Employees (FTE) 2025: 1.5 ▲ 0.4 vs 2024 (1.1) Unchanged	▲ 0.4

Key figures of Apotheek As, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek As?

What happened at Apotheek As in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 13, 2026 New annual accounts for financial year 2025: profit of € 42,742 (▼ 60% vs 2024). Source: NBB ↗
2024 CURAMIS BV became a director. NBB
2024 ARKOPHAR BV became a director. NBB
Mar 1, 1988 New establishment in As. KBO
Feb 11, 1988 Start of the company according to the CBE. KBO

In short

From € 143,063 profit in 2022 to € 42,742 profit in 2025.

Paid € 157,098 in corporate taxes since 2022.

Best year ever: 2023, with € 330,800 profit.

On average € 82,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

CURAMIS BV ARKOPHAR BV

Apotheek As

Behind Apotheek As are CURAMIS BV and ARKOPHAR BV.

Directors

According to the 2025 annual accounts

CURAMIS BV

Director · represented by BEMELMANS GOELE

since 2024

ARKOPHAR BV

Director · represented by ARKOUDOPOULOS KATERINA

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Steenweg 30

3665 As

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekas.be

Technologies

AWS S3BootstrapChart.jsCloudflare CDNDiviElementorFacebook PixelFont AwesomeGoogle FontsOwl CarouselPHPWP RocketWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja

Languages NL

Features

Webshop Blog Ads Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0433.387.981

VAT number

BE 0433.387.981

Registered office

Steenweg 30, 3665 As

Names & denominations

Apotheek As

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

11 February 1988

Peppol

Active · Active since 10 Oct 2024

Contact

apotheekas.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in cosmetica en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek As

Financials

What happened to Apotheek As?

Management

Directors

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions